Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity

Journal of Immunology

Volumn 156, Issue 10, 1996, Pages 3858-3865

  Levitsky, Hyam I ^a   Montgomery, Jami ^a   Ahmadzadeh, Mojgan ^a   Staveley O'Carroll, Kevin ^a   Guarnieri, Frank ^a   Longo, Dan L ^b   Kwak, Larry W ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD80; EPITOPES; FEMALE; GRAFT REJECTION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNIZATION, PASSIVE; INTERLEUKIN-4; LYMPHOCYTE TRANSFUSION; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029963944     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Pardoll, D M 1995 Paracrine cytokine adjuvants in cancer immunotherapy. Annu Rev. Immunol. 13:399.
2. Houghton, A N 1994. Cancer antigens: immune recognition of self and altered self. J. Exp Med. 180:1.
3. Huang, A. Y , P. Golumbek, M Ahmadzadeh, E Jaffee, D. Pardoll, and H. I. Levitsky 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science. 264:961
4. Huang, A. Y. C., A. T Bruce, D. M. Pardoll, and H. I Levilsky 1996. Does B7-1 expression confer antigen presenting cell capacity to tumors in vivo? J. Exp. Med 183:769.
5. Ashwell, J. D., A. L. DeFranco, W. E. Paul, and R. H Schwartz. 1984 Antigen presentation by resting B cells. radiosensitivity of the antigen-presentation function and two distinct pathways of T cell activation. J. Exp Med 159:881.
6. Lanzavecchia, A 1985. Antigen-specific interaction between T and B cells Nature 314:537
7. Ronchese, R., and B. Hausmann. 1993. B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes J. Exp. Med. 177:679
8. Lassila, O , O Vainio, and P. Matzinger. 1988. Can B cells turn on virgin T cells? Nature 334:253.
9. Fuchs, E. J , and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258 1156.
10. Eynon, E. E , and D. C. Parker 1992. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175:131.
11. Kwak, L. W., M. J. Campbell, D. K Czerwinski, S. Hart, R A Miller, and R. Levy. 1992 Induction of immune responses in patients with B-cell lymphoma against the surface immunoglobulin idiotype expressed by their tumors N Engl. J Med. 327:1209.
12. Campbell, M. J., L. Esserman, N. E. Byar, A. C. Allison, and R. Levy 1990. Idiotype vaccination against murine B cell lymphoma: humoral and cellular requirements for the full expression of antitumor immunity J. Immunol 145:1029.
13. 1. J Immunol 138:628
14. Wilson, A., A. J. T. George, C. A. King, and F. K. Stevenson. 1987. Recognition of a B cell lymphoma by anti-idiotypic T cell. J Immunol. 145:3937
15. Linsley, P S., W Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
16. Fearon, E. R., D. M. Pardoll, T. Itaya, P. Golumbek, H I. Levitsky, J. W. Simons. H Karasuyama, B. Vogelstein, and P. Frost. 1990. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response Cell 60:397.
17. Golumbek, P. T., A J. Lazenby, H. I. Levitsky, L. M. Jaffee, H. Karasuyama, M Baker, and D. M. Pardoll 1991. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254:713.
18. Dranoff, G, E Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H Hamada, D Pardoll, and R. C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl Acad Sci. USA 90:3539.
19. + single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med. 180:25.
20. Dialynas, D. M., Z S Quan, K. A. Wall, A Pierres, J Quintans, M R Loken, M. Pierre, and F Fitch. 1983. Characterization of the murine T cell surface molecule, designated L3T4, identified by the monoclonal antibody GK1 5. J Immunol 131:2445.
21. Sarmiento, M., A L Glasebrook, and F. W Fitch. 1980 IgG and IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665.
22. Eshhar, Z., C. Blatt, Y. Bergman, and J. Haimovich. 1979. Induction of secretion of IgM from cells of the B cell line 38C-13 by somatic cell hybridization J. Immunol 122:2430
23. Glimcher, L H , K. J Kim, I. Green, and W. E. Paul. 1982. Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells J. Exp. Med 155:445.
24. Tepper, R. I . P. K. Pattengale, and P. I Leder. 1989. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57:503.
25. Gansbacher, B . K Zier, B Daniels, K. Cronin, R Bannerji, and E. Gilboa. 1990. Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity J Exp. Med. 172:1217
26. Chen, L, S. Ash, W. A Brady, I. Hellstrom, K. E Hellstrom, K. A. Ledbetter, P. McGowan, and P. A. Linsley 1992. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71: 1093.
27. + T cells by B7-transfected melanoma cells 1993. Science 259 368.
28. Baskar, S., S. Ostrand-Rosenberg, N Nabavi, L. M. Nadler, G J Freeman, and L. H. Glimcher 1993 Constitutive expression of B7 restorer immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 90:5687.
29. Schultze, J. L., A A Cardoso, G J. Freeman, M J Seamon, J Daley, G S. Pinkus, J. G Gribben, and L M Nadler 1994. Follicular lymphomas can be induced to present alloantigens efficiently a conceptual model to improve their tumor immunogenicity Proc. Natl Acad. Sci. USA 92:8200.
30. Chen, L., P. McGowan, S Ashe, J Johnston, Y. Li, I. Hellstrom, and K E. Hellstrom. 1994. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp Med. 179:523.
31. Wu, T. C., A. Y C. Huang, E M. Jaffee, H I. Levitsky, and D. M Pardoll. 1995. A reassessment of the role of B7-1 expression in tumor rejection J. Exp. Med 182:1415.
32. + tumor cells. J. Immunol. 149 2391
33. Hathcock, K S , G. Laszlo, H. B Dickler, J. Bradshaw, P. Linsley, and R. J. Hodes 1993. Identification of an alternative CTLA-4 Ligand costimulatory for T cell activation Science 262 905.
34. Freeman, G J., F. Borriello, R. J. Hodes, H. Reiser, K. S. Hathcock, G. Laszlo, A. J. McKnight, J Kim, L. Du, D. B. Lombard, G. S Gray, L. M. Nadler, and A H Sharpe 1993. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262:907.
35. Weiss, S. and B Bogen 1989. B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells Proc. Natl Acad. Sci. USA 86:282.
36. Chakrabarti, D., and S. K. Ghosh. 1992. Induction of syngeneic cytotoxic T lymphocytes against a B cell tumor. 1. Role of idiotypic immunoglobulin. Cell. Immunol 142:54.
37. Chakrabarti, D , and S. K Ghosh. 1992. Induction of syngeneic cytotoxic T lymphocytes against a B cell tumor, in MHC class I-restricted CTL recognizes the processed form (s) of idiotype. Cell. Immunol. 144:455.
38. Kobrin, C B., and L W Kwak. 1994. The current status of human cancer vaccines. Exp. Opin Invest Drugs 3:1242.